Profile
Kaley Wilson currently works at Microbion Corp., as Director, Quark Venture, Inc., as Director-Business Development & Principal from 2016, and Crohn's & Colitis Canada (Canada), as Director from 2021.
Dr. Wilson also formerly worked at ARTMS, Inc., as Chief Executive Officer from 2018 to 2019 and Sitka Biopharma, Inc., as Chief Executive Officer.
Dr. Wilson received his doctorate degree from the University of British Columbia.
Kaley Wilson active positions
| Companies | Position | Start |
|---|---|---|
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Director/Board Member | - |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Private Equity Investor | 2016-09-30 |
Crohn?s & Colitis Canada
Crohn?s & Colitis Canada Miscellaneous Commercial ServicesCommercial Services Operates as a volunteer based charity that focused on finding the cures for crohn’s disease and ulcerative colitis & improving the lives of children and adults | Director/Board Member | 2021-04-30 |
Former positions of Kaley Wilson
| Companies | Position | End |
|---|---|---|
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel polymer platform technology that improves drug absorption for cancer treatments | Chief Executive Officer | 2022-05-31 |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Chief Executive Officer | 2019-09-09 |
Training of Kaley Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage pharmaceutical company | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc invests in companies located globally. The firm targets companies operating in the fields of innovative biotechnology and health sciences. It provides financing in the form of equity. | Finance |
Sitka Biopharma, Inc.
Sitka Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops novel polymer platform technology that improves drug absorption for cancer treatments | Health Technology |
ARTMS, Inc.
ARTMS, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Crohn?s & Colitis Canada
Crohn?s & Colitis Canada Miscellaneous Commercial ServicesCommercial Services Operates as a volunteer based charity that focused on finding the cures for crohn’s disease and ulcerative colitis & improving the lives of children and adults | Commercial Services |
- Stock Market
- Insiders
- Kaley Wilson
















